Assisted Reproductive Technology: Compelling solution for infertility

2018-05-14 11:05:38

Market Overview
According to a new report published by Reports Monitor titled, “Assisted Reproductive Technology Market by Technology, Procedure, and End-User: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the assisted reproductive technology market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. 

Assisted reproductive technology comprises all fertility treatments in which eggs are obtained from female ovaries and are merged with the sperms in the laboratory. The embryos then put back in the women’s body. Things that affect the success rate of ART include age or partners, reason of infertility, type of ART and many others. Though ART is expensive and time-consuming treatment it has permitted many couples to have children that otherwise would not have been conceived. The most common Complication of ART is multiple fetuses but this is a problem that can be prevented or minimized in several different ways.

More Insightful Information | Request a Sample Copy @

Increase in the infertility rates has led people to opt for human assisted reproductive technologies driving the growth of the market. Furthermore, growing stress level, obesity problem and rising per capta income favours the growth of the market. Additionally, increasing social acceptance of ART and government supportive programmes has been supporting the market expansion. However, lower rate of success, complication & risk along with high cost of the treatment might come across as obstacle to the ART market growth. Rising medical tourism owing to low cost of the treatment, developing healthcare infrastructure and great being great alternative for single parent or same-sex couple incorporate higher opportunities for the market. Nonetheless, reduced efficacy in older woman remains as a big challenge to the market. 

Europe ART market is majorly driven as large number of people is opting for it. Other factors include government auxiliary actions, increased awareness among people, growing prevalence of infertility and rising demand for medical tourism augment the growth of the market. 

ART market is segmented on the basis of technology, procedures, end-user and geography. In terms of technology the market is segregated into in vitro fertilization embryo transfer, artificial insemination, surrogacy and others. Based on procedure, the market is categorized into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Considering end-user segment the market is divided into fertility clinics, hospitals and others.

Competitive Landscape
The key players in the ART market include Merck KGaA, Parallabs, IrvineScientific, CooperSurgical, Inc., Ovascience, Cryolab Ltd., Nidacon International AB, Vitrolife AB, Laboratoire CCD and Hamilton Thorne, Inc.,.
For instance, Parallabs engaging advanced technologies for assisted reproduction launched Embryoscope, a time-lapse monitoring system in 2013. It enhanced the IVF system, elevated pregnancy rates, and was also utilized by the American Society of Reproductive Medicine.

About Garner Insights:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected] 

Related Press Releases